How I Diagnose and Treat Thrombocytopenia in the Geriatric Patient.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
13 Nov 2023
Historique:
accepted: 16 08 2023
received: 14 10 2022
revised: 31 07 2023
medline: 13 11 2023
pubmed: 13 11 2023
entrez: 13 11 2023
Statut: aheadofprint

Résumé

Thrombocytopenia in the elderly is a common but diagnostically challenging condition that has variable clinical impact to those affected. Diagnostic approach requires evaluation of pre-existing clinical conditions, detailed review of medications, and assessment for disorders that warrant urgent treatment. We describe a systematic approach to diagnosis of thrombocytopenia and present a schematic review for management strategies. Three clinical scenarios are presented that are relevant for their prevalence and management challenges in an elderly population. The first addresses primary immune thrombocytopenia (ITP) and reviews different treatment options. The second addresses complications of thrombocytopenia in management of the myelodysplastic syndrome (MDS). The last reviews diagnostic challenges of drug induced immune thrombocytopenia (DITP).

Identifiants

pubmed: 37956435
pii: 498686
doi: 10.1182/blood.2022017634
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 American Society of Hematology.

Auteurs

Patrick Foy (P)

Medical College of Wisconsin, MILWAUKEE, Wisconsin, United States.

Kenneth D Friedman (KD)

Versiti Blood Center of Wisconsin, United States.

Laura C Michaelis (LC)

Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Classifications MeSH